mRNA COVID-19 vaccine
Selected indexed studies
- mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation. (Curr Allergy Asthma Rep, 2023) [PMID:36689047]
- Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. (Vaccine, 2022) [PMID:36055877]
- COVID-19 mRNA Vaccine-induced Pneumonitis. (Intern Med, 2022) [PMID:34707048]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation. (2023) pubmed
- Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. (2022) pubmed
- COVID-19 mRNA Vaccine-induced Pneumonitis. (2022) pubmed
- The Covid-19 Vaccine-Development Multiverse. (2020) pubmed
- Do COVID-19 viral infection and its mRNA vaccine carry an equivalent risk of myocarditis? Review of the current evidence, insights, and future directions. (2023) pubmed
- Self-assembled mRNA vaccines. (2021) pubmed
- mRNA Covid-19 Vaccines in Pregnant Women. (2021) pubmed
- Panuveitis following mRNA-based COVID-19 vaccine. (2023) pubmed
- Anetoderma after mRNA COVID-19 vaccine. (2023) pubmed
- Autoimmune hepatitis following mRNA COVID-19 vaccine. (2023) pubmed